Cost-effectiveness of fluticasone propionate/salmeterol (500/50 μg) in the treatment of COPD
Stephanie R. Earnshaw, Michele R. Wilson, Anand A. Dalal, Mike G. Chambers, Priti Jhingran, Richard Stanford, Douglas W. MapelVolume:
103
Year:
2009
Language:
english
DOI:
10.1016/j.rmed.2008.10.005
File:
PDF, 295 KB
english, 2009